| miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma R Tejero, A Navarro, M Campayo, N Vinolas, RM Marrades, A Cordeiro, ... PloS one 9 (7), e101899, 2014 | 147 | 2014 |
| Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer M Campayo, A Navarro, N Vinolas, T Diaz, R Tejero, JM Gimferrer, ... European Respiratory Journal 41 (5), 1172-1178, 2013 | 87 | 2013 |
| A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma M Campayo, A Navarro, N Vinolas, R Tejero, C Munoz, T Diaz, ... PloS one 6 (7), e22509, 2011 | 83 | 2011 |
| Prognostic implications of miR‐16 expression levels in resected non‐small‐cell lung cancer A Navarro, T Diaz, E Gallardo, N Viñolas, RM Marrades, B Gel, ... Journal of surgical oncology 103 (5), 411-415, 2011 | 81 | 2011 |
| miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer M Campayo, A Navarro, JC Benítez, S Santasusagna, C Ferrer, M Monzó, ... PloS one 13 (11), e0206542, 2018 | 38 | 2018 |
| Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations M Riudavets, E Auclin, M Mosteiro, N Dempsey, M Majem, R Lobefaro, ... European Journal of Cancer 167, 142-148, 2022 | 35 | 2022 |
| Dihydropyrimidine dehydrogenases and cytidine‐deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant … JJ Grau, M Caballero, M Monzó, C Muñoz‐García, J Domingo‐Domenech, ... Journal of Surgical Oncology 98 (2), 130-134, 2008 | 27 | 2008 |
| SEOM clinical guideline for treatment of kidney cancer (2017) E Gallardo, MJ Méndez-Vidal, JL Perez-Gracia, JM Sepúlveda-Sánchez, ... Clinical and Translational Oncology 20, 47-56, 2018 | 25 | 2018 |
| Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel JJ Grau, M Caballero, M Campayo, S Jansa, M Vargas, L Alós, M Monzo The Laryngoscope 119 (8), 1484-1490, 2009 | 19 | 2009 |
| Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer M Campayo, N Viñolas, A Navarro, E Carcereny, F Casas, B Gel, T Diaz, ... Journal of Surgical Research 167 (1), e5-e12, 2011 | 11 | 2011 |
| Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel … F Casas, N Viñolas, F Ferrer, C Agustí, M Sanchez, JM Gimferrer, ... Journal of Thoracic Oncology 6 (1), 79-85, 2011 | 11 | 2011 |
| Prognostic and predictive factors for renal cell carcinoma C Suárez, M Campayo, R Bastús, S Castillo, O Etxanitz, M Guix, N Sala, ... Targeted Oncology 13, 309-331, 2018 | 9 | 2018 |
| Lincp21-RNA as predictive response marker for preoperative chemoradiotherapy in rectal cancer JC Benitez, M Campayo, T Díaz, C Ferrer, M Acosta-Plasencia, M Monzo, ... Journal of personalized medicine 11 (5), 420, 2021 | 7 | 2021 |
| Weekly cabazitaxel in" unfit" metastatic castration-resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment: Preliminary results of CABASEM-SOGUG … O Fernandez Calvo, E Fernandez Parra, B Perez-Valderrama, B Mellado, ... Journal of Clinical Oncology 33 (7_suppl), 167-167, 2015 | 3 | 2015 |
| Phase II study of weekly cabazitaxel for ‘unfit’metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment. Circulating tumour … U Anido, MJJ Fita, L Munielo-Romay, B Pérez-Valderrama, B Mellado, ... Annals of Oncology 27, vi255, 2016 | 2 | 2016 |
| Preliminary Results of a Phase Ii Study of Weekly Cabazitaxel in" Unfit" Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Progressing After Docetaxel Treatment … B Perez-Valderrama, B Mellado, MJ Juan, O Fernandez, ... Annals of Oncology 25, iv270, 2014 | 2 | 2014 |
| Genitourinary tumors, non-prostate A Ravaud, C Barrios, Ö Anak, D Pelov, A Louveau, B Alekseev, T MH, ... Annals of Oncology-English Edition 23 (9), ix258, 2012 | 2 | 2012 |
| Clinical factors associated with long-term benefit in patients with metastatic renal cell carcinoma treated with axitinib: real-world AXILONG study Á Pinto, O Reig, C Iglesias, E Gallardo, X García-del Muro, T Alonso, ... Clinical Genitourinary Cancer 20 (1), 25-34, 2022 | 1 | 2022 |
| External validation of a prognostic score in first-line metastastic castration-resistant prostate cancer (mCRPC) D Lorente, RL Mejorada, GAVO De de Rueda, AS Hernandez, MR Aliaga, ... Annals of Oncology 30, v337-v338, 2019 | 1 | 2019 |
| Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area JC Benítez, M Campayo, S Call, R Bastús Archivos de bronconeumologia 54 (12), 637-638, 2018 | 1 | 2018 |
